Skip to content

ORTHANIMS

Active Private limited companyfounded 2021active for 5 yearsAllée de la Ferme 2, 4053 ChaudfontaineKBO/BCE: BE 0776.636.339

Lifetime

5 annual accounts with figures on one time axis
peak €219,230 (2025)
€219,230▲ 33.7%
peak €152,475 (2025)
€152,475▲ 32.5%
peak €102,022 (2023)
€55,561▲ 18×
€69,450▼ 52.7%
Board1 name since 2021
1 directorMORADI Shayan
Documentsfilings and deeds
28-07-20263 days before the deadline
2025micro format
Gross margin from €163,948 to €219,230Result from €115,063 to €152,475Dividend €100,000Equity from €3,086 to €55,561Debts from €146,789 to €69,4504 establishments registered

Key points

from the 2025 annual accounts

Equity

€55,561 ▲ 18×
€3,0902024€55,6002025

Equity rose in 2025 from €3,086 to €55,561.

Turnover

≈ €410,000 estimated

The micro format states no turnover.

Investments

€7,899 1.9 × depreciation
2021202220232025

Green is investment, beige is depreciation.

Liquidity

1.65 was 0.97 in 2024

Short-term debts fell from €146,789 to €69,450.

Filings

5 annual accounts 1 late
AprilJune31 JulyOctober20222024

The 2021 accounts came 31 days late. The other four were filed on time.

Position in the sector

€152,475

Higher net result than 81% of companies in human health. Sector median €60,070 · 20,754 companies.

Checked score

88
Excellent
Financially stronger than 55% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.2% 01-2025: 0.2%● unchanged vs 12-2024lowest value 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.3%▲ +0.1 percentage points vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 1.0%▲ +0.7 percentage points vs 07-2025highest value 09-2025: 1.0%● unchanged vs 08-2025highest value 10-2025: 1.0%● unchanged vs 09-2025 11-2025: 1.0%● unchanged vs 10-2025 12-2025: 1.0%● unchanged vs 11-2025 01-2026: 1.0%● unchanged vs 12-2025 02-2026: 1.0%● unchanged vs 01-2026 03-2026: 0.5%▼ -0.5 percentage points vs 02-2026 04-2026: 0.5%● unchanged vs 03-2026 05-2026: 0.5%● unchanged vs 04-2026 06-2026: 0.5%● unchanged vs 05-2026 07-2026: 0.5%● unchanged vs 06-2026 08-2026: 0.2%▼ -0.3 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026 11-2026: 0.2%● unchanged vs 10-2026

Financial strength
Strong

69+42equity 44.4% of total assets
22+22short-term debt 55.6% · cash 0.5%
100=return on assets 122.0%

Score breakdown

raises risk
Liquidity: current ratio 1.65, cash €569
Founded in 2021
lowers risk
Sector: Human health activities (NACE 86)
Figures for financial year 2025 (filed on 28-07-2026)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 36% of them on solvency, 3% on liquidity, 80% on profitability and 99% on growth.

The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as ORTHANIMS has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.4%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of ORTHANIMS itself is lower: 0.2% within 12 months. It rests on far more data about ORTHANIMS than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for ORTHANIMS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €4,500 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 1.65 (0.97 in 2024), above the usual 1.5. Short-term debt is 55.6% and cash 0.5% of total assets. However, 55.6% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Liquidity: current ratio 1.65, cash €569
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 28-07-2026)
NBB · annual accounts
raises risk · Founded in 2021
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
3 days early
2024
8 days early
2023
31 days early
2022
2 days early
2021
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 3 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

MS
Director, since 28-10-2021
  • MORADI Shayan 300 sharesdeed of 03-11-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0776636339
4 establishments registered Liège, Donceel, Sprimont and Seraing
Registered office moved from Liège to Embourg New registered office: Allée de la Ferme, 2 4053 Embourg · Previous registered office: rue Fabry 18, boite 22- 4000 Liège · Gazette deed
Incorporation Founding capital of €3,000, 300 shares · Founder: MORADI Shayan (comparant) · Appointment: MORADI Shayan (director) · published on 03-11-2021 · Gazette deed
All 14 events

Comparable companies

same main activity, similar in size and age
Company
ORTHANIMS Chaudfontaine €125,011 €219,230 44.4% -
DOCTEUR LOUISA SOUKANE Sprimont €159,791 €197,206 1.6% -
DIOS MEDICAL Ixelles €125,173 €203,282 4.2% -
ELKE VAN OOST GYNAECOLOGIE Sint-Pieters-Leeuw €124,896 €192,889 1.7% -
ENDOCRINOLOGIE AZ MARIA MIDDELARES Ghent €113,175 €203,405 34.1% -
GH Cardiologist Marche-en-Famenne €157,309 €231,756 1.0% -
VILLA MADELEINE Brussels €141,629 €181,257 20.5% -

These companies have the same main activity as ORTHANIMS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €113,000 and €160,000, founded between 2020 and 2022.

Official details

Source: KBO
Status
Active since 28-10-2021Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment units
2.323.759.9124053 Chaudfontaine, since 28-10-2021
2.372.747.7814020 Liège, since 07-04-2025and 3 others
Financial year end
31 December
Peppol
Reachable since 02-02-2026
Company details

Annual accounts 2025

€125,011▼ 16.6%
Employeeson 31-12-2025
1=
Filing
Filed on 28-07-2026, 3 days before the end of the filing period
Financials

Insights on ORTHANIMS

ORTHANIMS files the micro format. That format states no turnover. The gross margin rose from €4,388 in 2021 to €219,230 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ORTHANIMS

What is the company number of ORTHANIMS?
The company number of ORTHANIMS is 0776.636.339. The VAT number is the same number with BE in front: BE 0776.636.339.
Where is ORTHANIMS based?
The registered office is at Allée de la Ferme 2, 4053 Chaudfontaine.Company details
What does ORTHANIMS do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ORTHANIMS?
ORTHANIMS is a private limited company (BV).
When was ORTHANIMS founded?
ORTHANIMS was founded on 28-10-2021.
Is ORTHANIMS still active?
Yes, ORTHANIMS is an active enterprise in the KBO register.
How many employees does ORTHANIMS have?
ORTHANIMS had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of ORTHANIMS?
The turnover in financial year 2025 is ≈ €410,000. This figure is estimated from the gross margin of €219,230 and 41 comparable companies (NACE 86220). It probably lies between €350,000 and €540,000.
Is ORTHANIMS profitable?
In financial year 2025, ORTHANIMS made a profit of €152,475.
Where can I find the annual accounts of ORTHANIMS?
ORTHANIMS filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ORTHANIMS due?
ORTHANIMS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.